{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:53:00Z","timestamp":1789912380326,"version":"4.0.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T00:00:00Z","timestamp":1507852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/cr.2017.113","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T10:41:17Z","timestamp":1507891277000},"page":"1441-1465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models"],"prefix":"10.1038","volume":"27","author":[{"given":"Meng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiyin","family":"Hexige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouqing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,13]]},"reference":[{"key":"BFcr2017113_CR1","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1056\/NEJM199906243402507","volume":"340","author":"JB Martin","year":"1999","unstructured":"Martin JB . Molecular basis of the neurodegenerative disorders. N Engl J Med 1999; 340:1970\u20131980.","journal-title":"N Engl J Med"},{"key":"BFcr2017113_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto C . Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci 2003; 4:49\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"BFcr2017113_CR3","doi-asserted-by":"crossref","unstructured":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72:971\u2013983.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"BFcr2017113_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399403006549","volume":"5","author":"DC Rubinsztein","year":"2003","unstructured":"Rubinsztein DC, Carmichael J . Huntington's disease: molecular basis of neurodegeneration. Expert Rev Mol Med 2003; 5:1\u201321.","journal-title":"Expert Rev Mol Med"},{"key":"BFcr2017113_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ, Hen R . Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 2000; 101:57\u201366.","journal-title":"Cell"},{"key":"BFcr2017113_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron E, Denovan-Wright EM, Nash K, Lewin AS, Mandel RJ . Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice. Mol Ther 2005; 12:618\u2013633.","journal-title":"Mol Ther"},{"key":"BFcr2017113_CR7","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X, et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci USA 2005; 102:5820\u20135825.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr2017113_CR8","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia M, Sena-Esteves M, Chase K, et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci USA 2007; 104:17204\u201317209.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr2017113_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, et al. Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron 2012; 74:1031\u20131044.","journal-title":"Neuron"},{"key":"BFcr2017113_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nchembio.1790","volume":"11","author":"M Jimenez-Sanchez","year":"2015","unstructured":"Jimenez-Sanchez M, Lam W, Hannus M, et al. siRNA screen identifies QPCT as a druggable target for Huntington's disease. Nat Chem Biol 2015; 11:347\u2013354.","journal-title":"Nat Chem Biol"},{"key":"BFcr2017113_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S . Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004; 431:805\u2013810.","journal-title":"Nature"},{"key":"BFcr2017113_CR12","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nchembio.694","volume":"7","author":"J Miller","year":"2011","unstructured":"Miller J, Arrasate M, Brooks E, et al. Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol 2011; 7:925\u2013934.","journal-title":"Nat Chem Biol"},{"key":"BFcr2017113_CR13","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1096\/fj.12-219220","volume":"27","author":"B Lu","year":"2013","unstructured":"Lu B, Palacino J . A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J 2013; 27:1820\u20131829.","journal-title":"FASEB J"},{"key":"BFcr2017113_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature12204","volume":"498","author":"J Park","year":"2013","unstructured":"Park J, Al-Ramahi I, Tan Q, et al. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature 2013; 498:325\u2013331.","journal-title":"Nature"},{"key":"BFcr2017113_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O'Kusky JR, et al. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995; 81:811\u2013823.","journal-title":"Cell"},{"key":"BFcr2017113_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, et al. Inactivation of the mouse Huntington's disease gene homolog Hdh . Science 1995; 269:407\u2013410.","journal-title":"Science"},{"key":"BFcr2017113_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nn.4014","volume":"18","author":"K Becanovic","year":"2015","unstructured":"Becanovic K, Norremolle A, Neal SJ, et al. A SNP in the HTT promoter alters NF-kappaB binding and is a bidirectional genetic modifier of Huntington disease. Nat Neurosci 2015; 18:807\u2013816.","journal-title":"Nat Neurosci"},{"key":"BFcr2017113_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","volume":"395","author":"A Weiss","year":"2009","unstructured":"Weiss A, Abramowski D, Bibel M, et al. Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease. Anal Biochem 2009; 395:8\u201315.","journal-title":"Anal Biochem"},{"key":"BFcr2017113_CR19","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/clinchem\/39.9.1953","volume":"39","author":"G Mathis","year":"1993","unstructured":"Mathis G . Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin Chem 1993; 39:1953\u20131959.","journal-title":"Clin Chem"},{"key":"BFcr2017113_CR20","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1002\/cbic.200900131","volume":"10","author":"P Paganetti","year":"2009","unstructured":"Paganetti P, Weiss A, Trapp M, et al. Development of a method for the high-throughput quantification of cellular proteins. Chembiochem 2009; 10:1678\u20131688.","journal-title":"Chembiochem"},{"key":"BFcr2017113_CR21","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/JCI64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss A, Trager U, Wild EJ, et al. Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression. J Clin Invest 2012; 122:3731\u20133736.","journal-title":"J Clin Invest"},{"key":"BFcr2017113_CR22","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1212\/WNL.0b013e3182a55ede","volume":"81","author":"M Moscovitch-Lopatin","year":"2013","unstructured":"Moscovitch-Lopatin M, Goodman RE, Eberly S, et al. HTRF analysis of soluble huntingtin in PHAROS PBMCs. Neurology 2013; 81:1134\u20131140.","journal-title":"Neurology"},{"key":"BFcr2017113_CR23","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/gb-2009-10-11-r130","volume":"10","author":"C Wu","year":"2009","unstructured":"Wu C, Orozco C, Boyer J, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 2009; 10:R130.","journal-title":"Genome Biol"},{"key":"BFcr2017113_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012; 489:391\u2013399.","journal-title":"Nature"},{"key":"BFcr2017113_CR25","doi-asserted-by":"publisher","first-page":"13675","DOI":"10.1074\/jbc.271.23.13675","volume":"271","author":"T Moriguchi","year":"1996","unstructured":"Moriguchi T, Kuroyanagi N, Yamaguchi K, et al. A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem 1996; 271:13675\u201313679.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR26","doi-asserted-by":"publisher","first-page":"17090","DOI":"10.1074\/jbc.M307629200","volume":"279","author":"JF Curtin","year":"2004","unstructured":"Curtin JF, Cotter TG . JNK regulates HIPK3 expression and promotes resistance to Fas-mediated apoptosis in DU 145 prostate carcinoma cells. J Biol Chem 2004; 279:17090\u201317100.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR27","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel F, Rigamonti D, Hilditch-Maguire P, et al. Dominant phenotypes produced by the HD mutation in STHdh (Q111) striatal cells. Hum Mol Genet 2000; 9:2799\u20132809.","journal-title":"Hum Mol Genet"},{"key":"BFcr2017113_CR28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JHD-140104","volume":"3","author":"Y Liang","year":"2014","unstructured":"Liang Y, Yao Y, Lu M, Hou J, Yu S, Lu B . TR-FRET assays for endogenous huntingtin protein level in mouse cells. J Huntingtons Dis 2014; 3:253\u2013259.","journal-title":"J Huntingtons Dis"},{"key":"BFcr2017113_CR29","doi-asserted-by":"publisher","first-page":"doi: 10.7554\/eL","DOI":"10.7554\/eLife.05449","volume":"4","author":"Y Yao","year":"2015","unstructured":"Yao Y, Cui X, Al-Ramahi I, et al. A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity. Elife 2015; 4. doi: 10.7554\/eLife.05449.","journal-title":"Elife"},{"key":"BFcr2017113_CR30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nn.3367","volume":"16","author":"B Lu","year":"2013","unstructured":"Lu B, Al-Ramahi I, Valencia A, et al. Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance. Nat Neurosci 2013; 16:562\u2013570.","journal-title":"Nat Neurosci"},{"key":"BFcr2017113_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1095\/biolreprod.115.138057","volume":"94","author":"N Warr","year":"2016","unstructured":"Warr N, Siggers P, Carre GA, Wells S, Greenfield A . Genetic analyses reveal functions for MAP2K3 and MAP2K6 in mouse testis determination. Biol Reprod 2016; 94:103.","journal-title":"Biol Reprod"},{"key":"BFcr2017113_CR32","doi-asserted-by":"publisher","first-page":"3318","DOI":"10.1007\/s00125-012-2711-1","volume":"55","author":"N Shojima","year":"2012","unstructured":"Shojima N, Hara K, Fujita H, et al. Depletion of homeodomain-interacting protein kinase 3 impairs insulin secretion and glucose tolerance in mice. Diabetologia 2012; 55:3318\u20133330.","journal-title":"Diabetologia"},{"key":"BFcr2017113_CR33","doi-asserted-by":"publisher","first-page":"10454","DOI":"10.1128\/MCB.25.23.10454-10464.2005","volume":"25","author":"VA Beardmore","year":"2005","unstructured":"Beardmore VA, Hinton HJ, Eftychi C, et al. Generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 2005; 25:10454\u201310464.","journal-title":"Mol Cell Biol"},{"key":"BFcr2017113_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cne.10776","volume":"465","author":"LB Menalled","year":"2003","unstructured":"Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF . Time course of early motor and neuropathological anomalies in a knockin mouse model of Huntington's disease with 140 CAG repeats. J Comp Neurol 2003; 465:11\u201326.","journal-title":"J Comp Neurol"},{"key":"BFcr2017113_CR35","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1038\/srep05601","volume":"4","author":"X Cui","year":"2014","unstructured":"Cui X, Liang Q, Liang Y, Lu M, Ding Y, Lu B . TR-FRET assays of Huntingtin protein fragments reveal temperature and PolyQ length-dependent conformational changes. Sci Rep 2014; 4:5601.","journal-title":"Sci Rep"},{"key":"BFcr2017113_CR36","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","volume":"17","author":"J Hu","year":"2010","unstructured":"Hu J, Liu J, Corey DR . Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. Chem Biol 2010; 17:1183\u20131188.","journal-title":"Chem Biol"},{"key":"BFcr2017113_CR37","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.33359","volume":"64","author":"D Hammaker","year":"2012","unstructured":"Hammaker D, Topolewski K, Edgar M, et al. Decreased collagen-induced arthritis severity and adaptive immunity in MKK-6-deficient mice. Arthritis Rheum 2012; 64:678\u2013687.","journal-title":"Arthritis Rheum"},{"key":"BFcr2017113_CR38","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1096\/fj.02-0869fje","volume":"17","author":"H Suzuki","year":"2003","unstructured":"Suzuki H, Wu J, Hossain K, et al. Involvement of MKK6 in TCRalphabeta(int)CD69lo: a target population for apoptotic cell death in thymocytes. FASEB J 2003; 17:1538\u20131540.","journal-title":"FASEB J"},{"key":"BFcr2017113_CR39","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1523\/JNEUROSCI.4965-11.2013","volume":"33","author":"DM Taylor","year":"2013","unstructured":"Taylor DM, Moser R, Regulier E, et al. MAP kinase phosphatase 1 (MKP-1\/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition. J Neurosci 2013; 33:2313\u20132325.","journal-title":"J Neurosci"},{"key":"BFcr2017113_CR40","doi-asserted-by":"publisher","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf A, Hoss AG, Lagomarsino V, et al. RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS One 2015; 10:e0143563.","journal-title":"PLoS One"},{"key":"BFcr2017113_CR41","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1074\/jbc.272.31.19509","volume":"272","author":"B Stein","year":"1997","unstructured":"Stein B, Yang MX, Young DB, et al. p38-2, a novel mitogen-activated protein kinase with distinct properties. J Biol Chem 1997; 272:19509\u201319517.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR42","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/hmg\/dds516","volume":"22","author":"A Valencia","year":"2013","unstructured":"Valencia A, Sapp E, Kimm JS, et al. Elevated NADPH oxidase activity contributes to oxidative stress and cell death in Huntington's disease. Hum Mol Genet 2013; 22:1112\u20131131.","journal-title":"Hum Mol Genet"},{"key":"BFcr2017113_CR43","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1074\/jbc.273.4.2161","volume":"273","author":"Y Wang","year":"1998","unstructured":"Wang Y, Huang S, Sah VP, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998; 273:2161\u20132168.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR44","doi-asserted-by":"publisher","first-page":"13846","DOI":"10.1021\/bi980832y","volume":"37","author":"B Frantz","year":"1998","unstructured":"Frantz B, Klatt T, Pang M, et al. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 1998; 37:13846\u201313853.","journal-title":"Biochemistry"},{"key":"BFcr2017113_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cell.2008.02.047","volume":"133","author":"M Varjosalo","year":"2008","unstructured":"Varjosalo M, Bjorklund M, Cheng F, et al. Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 2008; 133:537\u2013548.","journal-title":"Cell"},{"key":"BFcr2017113_CR46","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1084\/jem.192.8.1165","volume":"192","author":"V Rochat-Steiner","year":"2000","unstructured":"Rochat-Steiner V, Becker K, Micheau O, et al. FIST\/HIPK3: a Fas\/FADD-interacting serine\/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation. J Exp Med 2000; 192:1165\u20131174.","journal-title":"J Exp Med"},{"key":"BFcr2017113_CR47","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/nbt.1990","volume":"29","author":"MI Davis","year":"2011","unstructured":"Davis MI, Hunt JP, Herrgard S, et al. Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol 2011; 29:1046\u20131051.","journal-title":"Nat Biotechnol"},{"key":"BFcr2017113_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s12031-012-9739-z","volume":"47","author":"R Wang","year":"2012","unstructured":"Wang R, Luo Y, Ly PT, et al. Sp1 regulates human huntingtin gene expression. J Mol Neurosci 2012; 47:311\u2013321.","journal-title":"J Mol Neurosci"},{"key":"BFcr2017113_CR49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4161\/auto.4600","volume":"3","author":"N Mizushima","year":"2007","unstructured":"Mizushima N, Yoshimori T . How to interpret LC3 immunoblotting. Autophagy 2007; 3:542\u2013545.","journal-title":"Autophagy"},{"key":"BFcr2017113_CR50","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.05.040","volume":"47","author":"S Luo","year":"2012","unstructured":"Luo S, Garcia-Arencibia M, Zhao R, et al. Bim inhibits autophagy by recruiting Beclin 1 to microtubules. Mol Cell 2012; 47:359\u2013370.","journal-title":"Mol Cell"},{"key":"BFcr2017113_CR51","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","volume":"137","author":"R Mathew","year":"2009","unstructured":"Mathew R, Karp CM, Beaudoin B, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137:1062\u20131075.","journal-title":"Cell"},{"key":"BFcr2017113_CR52","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.4161\/auto.20441","volume":"8","author":"MK Hancock","year":"2012","unstructured":"Hancock MK, Hermanson SB, Dolman NJ . A quantitative TR-FRET plate reader immunoassay for measuring autophagy. Autophagy 2012; 8:1227\u20131244.","journal-title":"Autophagy"},{"key":"BFcr2017113_CR53","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1074\/jbc.M111.307603","volume":"287","author":"HC Lan","year":"2012","unstructured":"Lan HC, Wu CF, Shih HM, Chung BC . Death-associated protein 6 (Daxx) mediates cAMP-dependent stimulation of Cyp11a1 (P450scc) transcription. J Biol Chem 2012; 287:5910\u20135916.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR54","doi-asserted-by":"publisher","first-page":"15406","DOI":"10.1074\/jbc.M115.658765","volume":"290","author":"LA Puto","year":"2015","unstructured":"Puto LA, Brognard J, Hunter T . Transcriptional repressor DAXX promotes prostate cancer tumorigenicity via suppression of autophagy. J Biol Chem 2015; 290:15406\u201315420.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR55","doi-asserted-by":"crossref","unstructured":"HD iPSC Consortium. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 2012; 11:264\u2013278.","DOI":"10.1016\/j.stem.2012.04.027"},{"key":"BFcr2017113_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neures.2015.02.009","volume":"97","author":"JF Daneault","year":"2015","unstructured":"Daneault JF, Carignan B, Sadikot AF, Duval C . Inter-limb coupling during diadochokinesis in Parkinson's and Huntington's disease. Neurosci Res 2015; 97:60\u201368.","journal-title":"Neurosci Res"},{"key":"BFcr2017113_CR57","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.gaitpost.2009.04.009","volume":"30","author":"DS Mandeville","year":"2009","unstructured":"Mandeville DS, Osternig LR, Lantz BA, Mohler CG, Chou LS . A multivariate statistical ranking of clinical and gait measures before and after total knee replacement. Gait Posture 2009; 30:197\u2013200.","journal-title":"Gait Posture"},{"key":"BFcr2017113_CR58","doi-asserted-by":"publisher","first-page":"e1003042","DOI":"10.1371\/journal.pgen.1003042","volume":"8","author":"JP Miller","year":"2012","unstructured":"Miller JP, Yates BE, Al-Ramahi I, et al. A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease. PLoS Genet 2012; 8:e1003042.","journal-title":"PLoS Genet"},{"key":"BFcr2017113_CR59","doi-asserted-by":"publisher","first-page":"e7275","DOI":"10.1371\/journal.pone.0007275","volume":"4","author":"J Doumanis","year":"2009","unstructured":"Doumanis J, Wada K, Kino Y, Moore AW, Nukina N . RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation. PLoS One 2009; 4:e7275.","journal-title":"PLoS One"},{"key":"BFcr2017113_CR60","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1534\/genetics.109.112516","volume":"184","author":"S Zhang","year":"2010","unstructured":"Zhang S, Binari R, Zhou R, Perrimon N . A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 2010; 184:1165\u20131179.","journal-title":"Genetics"},{"key":"BFcr2017113_CR61","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuron.2010.06.021","volume":"67","author":"JP Miller","year":"2010","unstructured":"Miller JP, Holcomb J, Al-Ramahi I, et al. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron 2010; 67:199\u2013212.","journal-title":"Neuron"},{"key":"BFcr2017113_CR62","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A . Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 1995; 11:155\u2013163.","journal-title":"Nat Genet"},{"key":"BFcr2017113_CR63","doi-asserted-by":"crossref","unstructured":"Rodan LH, Cohen J, Fatemi A, et al. A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene. Eur J Hum Genet 2016.","DOI":"10.1038\/ejhg.2016.112"},{"key":"BFcr2017113_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.nbd.2016.09.006","volume":"96","author":"EE Arteaga-Bracho","year":"2016","unstructured":"Arteaga-Bracho EE, Gulinello M, Winchester ML, et al. Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease. Neurobiol Dis 2016; 96:144\u2013155.","journal-title":"Neurobiol Dis"},{"key":"BFcr2017113_CR65","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/brain\/awr333","volume":"135","author":"R Grondin","year":"2012","unstructured":"Grondin R, Kaytor MD, Ai Y, et al. Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum. Brain 2012; 135:1197\u20131209.","journal-title":"Brain"},{"key":"BFcr2017113_CR66","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1073\/pnas.1524575113","volume":"113","author":"G Wang","year":"2016","unstructured":"Wang G, Liu X, Gaertig MA, Li S, Li XJ . Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis. Proc Natl Acad Sci USA 2016; 113:3359\u20133364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr2017113_CR67","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V, Hassig R, et al. Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 2009; 65:276\u2013285.","journal-title":"Ann Neurol"},{"key":"BFcr2017113_CR68","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, et al. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. Mol Ther 2009; 17:1053\u20131063.","journal-title":"Mol Ther"},{"key":"BFcr2017113_CR69","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1021\/bi101208k","volume":"49","author":"KT Gagnon","year":"2010","unstructured":"Gagnon KT, Pendergraff HM, Deleavey GF, et al. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry 2010; 49:10166\u201310178.","journal-title":"Biochemistry"},{"key":"BFcr2017113_CR70","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","volume":"108","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Engelman J, Friedlander RM . Allele-specific silencing of mutant Huntington's disease gene. J Neurochem 2009; 108:82\u201390.","journal-title":"J Neurochem"},{"key":"BFcr2017113_CR71","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1089\/hum.2007.116","volume":"19","author":"PH van Bilsen","year":"2008","unstructured":"van Bilsen PH, Jaspers L, Lombardi MS, et al. Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts. Hum Gene Ther 2008; 19:710\u2013719.","journal-title":"Hum Gene Ther"},{"key":"BFcr2017113_CR72","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87:493\u2013506.","journal-title":"Cell"},{"key":"BFcr2017113_CR73","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/hmg\/ddh175","volume":"13","author":"G Schilling","year":"2004","unstructured":"Schilling G, Savonenko AV, Klevytska A, et al. Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic mice. Hum Mol Genet 2004; 13:1599\u20131610.","journal-title":"Hum Mol Genet"},{"key":"BFcr2017113_CR74","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 2003; 12:1555\u20131567.","journal-title":"Hum Mol Genet"},{"key":"BFcr2017113_CR75","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, et al. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 2008; 28:6182\u20136195.","journal-title":"J Neurosci"},{"key":"BFcr2017113_CR76","doi-asserted-by":"publisher","first-page":"e49838","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175. PLoS One 2012; 7:e49838.","journal-title":"PLoS One"},{"key":"BFcr2017113_CR77","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nn.4256","volume":"19","author":"P Langfelder","year":"2016","unstructured":"Langfelder P, Cantle JP, Chatzopoulou D, et al. Integrated genomics and proteomics define huntingtin CAG length-dependent networks in mice. Nat Neurosci 2016; 19:623\u2013633.","journal-title":"Nat Neurosci"},{"key":"BFcr2017113_CR78","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/nbt.3587","volume":"34","author":"V Alexandrov","year":"2016","unstructured":"Alexandrov V, Brunner D, Menalled LB, et al. Large-scale phenome analysis defines a behavioral signature for Huntington's disease genotype in mice. Nat Biotechnol 2016; 34:838\u2013844.","journal-title":"Nat Biotechnol"},{"key":"BFcr2017113_CR79","doi-asserted-by":"publisher","first-page":"16889","DOI":"10.1073\/pnas.1420103111","volume":"111","author":"J Ochaba","year":"2014","unstructured":"Ochaba J, Lukacsovich T, Csikos G, et al. Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc Natl Acad Sci USA 2014; 111:16889\u201316894.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcr2017113_CR80","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/ncb3101","volume":"17","author":"YN Rui","year":"2015","unstructured":"Rui YN, Xu Z, Patel B, et al. Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol 2015; 17:262\u2013275.","journal-title":"Nat Cell Biol"},{"key":"BFcr2017113_CR81","doi-asserted-by":"publisher","first-page":"10949","DOI":"10.1523\/JNEUROSCI.1043-15.2015","volume":"35","author":"OR Joassard","year":"2015","unstructured":"Joassard OR, Belanger G, Karmouch J, et al. HuR mediates changes in the stability of AChR beta-subunit mRNAs after skeletal muscle denervation. J Neurosci 2015; 35:10949\u201310962.","journal-title":"J Neurosci"},{"key":"BFcr2017113_CR82","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cell.2009.06.044","volume":"139","author":"Z Paroo","year":"2009","unstructured":"Paroo Z, Ye X, Chen S, Liu Q . Phosphorylation of the human microRNA-generating complex mediates MAPK\/Erk signaling. Cell 2009; 139:112\u2013122.","journal-title":"Cell"},{"key":"BFcr2017113_CR83","doi-asserted-by":"publisher","first-page":"16957","DOI":"10.1074\/jbc.M212049200","volume":"278","author":"K Merienne","year":"2003","unstructured":"Merienne K, Helmlinger D, Perkin GR, Devys D, Trottier Y . Polyglutamine expansion induces a protein-damaging stress connecting heat shock protein 70 to the JNK pathway. J Biol Chem 2003; 278:16957\u201316967.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR84","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1126\/science.1215156","volume":"335","author":"ES Blum","year":"2012","unstructured":"Blum ES, Abraham MC, Yoshimura S, Lu Y, Shaham S . Control of nonapoptotic developmental cell death in Caenorhabditis elegans by a polyglutamine-repeat protein. Science 2012; 335:970\u2013973.","journal-title":"Science"},{"key":"BFcr2017113_CR85","doi-asserted-by":"publisher","first-page":"13487","DOI":"10.1074\/jbc.M111.286609","volume":"287","author":"E Sapp","year":"2012","unstructured":"Sapp E, Valencia A, Li X, et al. Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer. J Biol Chem 2012; 287:13487\u201313499.","journal-title":"J Biol Chem"},{"key":"BFcr2017113_CR86","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","volume":"56","author":"J Ko","year":"2001","unstructured":"Ko J, Ou S, Patterson PH . New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Brain Res Bull 2001; 56:319\u2013329.","journal-title":"Brain Res Bull"},{"key":"BFcr2017113_CR87","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2013.04.016","volume":"153","author":"K Leppek","year":"2013","unstructured":"Leppek K, Schott J, Reitter S, Poetz F, Hammond MC, Stoecklin G . Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. Cell 2013; 153:869\u2013881.","journal-title":"Cell"},{"key":"BFcr2017113_CR88","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/aps.2016.31","volume":"37","author":"P Wu","year":"2016","unstructured":"Wu P, Lu MX, Cui XT, et al. A high-throughput-compatible assay to measure the degradation of endogenous Huntingtin proteins. Acta Pharmacol Sin 2016; 37:1307\u20131314.","journal-title":"Acta Pharmacol Sin"}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cr2017113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cr2017113","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cr.2017.113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/cr2017113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:39:12Z","timestamp":1684417152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cr2017113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,13]]},"references-count":88,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFcr2017113"],"URL":"https:\/\/doi.org\/10.1038\/cr.2017.113","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,13]]},"assertion":[{"value":"16 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}